Gavin Corcoran, MD FACP

Physician-executive with 15+ years of senior R&D and Chief Medical Officer leadership across big pharma, mid-cap specialty, and small-cap gene therapy and AI-enabled biotech.

Currently Chief Development Officer at Formation Bio, an AI-driven drug development company in New York. Previously led R&D at Axovant Gene Therapies (CNS gene therapy) and served as CMO of Allergan / Actavis across one of the broadest therapeutic-area portfolios in the industry; CNS, CV, metabolic, respiratory, women's health, GI, anti-infectives, urology, and dermatology. Earlier ran Global Medicines Development at Forest Laboratories. Brings rare top-to-bottom drug development perspective: early development through medical affairs, generics through gene therapy, single-asset biotech through diversified specialty pharma.